| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 526,944 | 580,924 | 573,715 | 600,709 | | Cost of Revenue | 231,984 | 252,442 | 252,494 | 265,826 | | | Gross Profit | 294,960 | 328,482 | 321,221 | 334,883 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 160,406 | 157,844 | 161,708 | 168,097 | | Non Recurring |
-
| 9,408 |
-
|
-
| | Others | 33,689 | 34,660 | 35,537 | 35,409 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 100,865 | 126,570 | 123,976 | 131,377 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,902 | (11,485) | (1,487) | (4,799) | | Earnings Before Interest And Taxes | 106,767 | 115,085 | 122,489 | 126,578 | | Interest Expense | 9,476 | 11,836 | 12,119 | 11,970 | | Income Before Tax | 97,291 | 103,249 | 110,370 | 114,608 | | Income Tax Expense | (37,165) | 4,781 | 34,458 | 36,913 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 134,456 | 98,468 | 75,912 | 77,695 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 134,456 | 98,468 | 75,912 | 77,695 | | Preferred Stock And Other Adjustments | (1,124) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $133,332 | $98,468 | $75,912 | $77,695 |
|
0.45% Nasdaq 
0.20%
Income Statement
